For instance, more than 500 million people worldwide carry at least one type of hepatitis virus (B or C), and many will develop clinically significant hepatic disease.1 Up to 25% of chronic carriers of hepatitis B virus (HBV) are at high risk of eventually dying from infection-related sequelae, such as end-stage cirrhosis and hepatocellular carcinoma, … Continue reading For instance, more than 500 million people worldwide carry at least one type of hepatitis virus (B or C), and many will develop clinically significant hepatic disease